Prokaryotic vs Eukaryotic Cells

Every cell on Earth belongs to one of three domains of life: Bacteria, Archaea, and Eukarya. The first two are grouped together at the cell-biology level as prokaryotes (from Greek pro = "before" + karyon = "nucleus"), while the third comprises the eukaryotes ("true nucleus"). This terminology is a structural claim, not merely a taxonomic label: it asserts that prokaryotic cells lack a membrane-bound nucleus, and that eukaryotic cells possess one. That single architectural fact is the root of nearly every other systematic difference between the two cell types. The deeper concept at stake is compartmentalization. A eukaryotic cell does not just wall off its DNA — it partitions its entire cytoplasm into discrete membrane-bound compartments (organelles), each with its own internal chemical environment, its own set of resident enzymes, and its own traffic rules for what molecules may enter or leave. A prokaryotic cell, by contrast, runs essentially all of its biochemistry in one continuous aqueous compartment, the cytoplasm, with only a plasma membrane separating "inside" from "outside." Prokaryotes are not simply "simpler" eukaryotes missing some parts; they represent an alternative, highly successful strategy that has dominated Earth's biomass and biogeochemistry for roughly 3.5 billion years — bacteria and archaea still outnumber eukaryotic cells by orders of magnitude and drive the planet's nitrogen and sulfur cycles. It is worth noting immediately that this dichotomy, while pedagogically essential, has known exceptions and blurred edges that the current consensus explicitly acknowledges: some bacteria (e.g., Planctomycetes) have internal membrane-bound compartments approaching nucleus-like organization, and giant viruses complicate any strict boundary — but for the vast majority of cells across the tree of life, the prokaryote/eukaryote structural split described here holds robustly.

1. The defining feature: nuclear envelope and genome packaging

In a prokaryotic cell, the genome is typically a single circular double-stranded DNA molecule, condensed by supercoiling and DNA-binding proteins (such as HU and H-NS in bacteria) into an irregular, non-membrane-bound region called the nucleoid. RNA polymerase, ribosomes, and metabolic enzymes have direct physical access to this DNA — there is no membrane to cross. Because transcription and translation occur in the same compartment, they are physically coupled: ribosomes begin translating an mRNA while RNA polymerase is still transcribing it downstream, producing polysome-like structures visible by electron microscopy. In a eukaryotic cell, the genome is organized into multiple linear chromosomes, each DNA molecule wound around histone octamers to form nucleosomes ("beads on a string"), further coiled into higher-order chromatin. This chromatin is enclosed within the nuclear envelope, a double lipid bilayer continuous with the endoplasmic reticulum, studded with nuclear pore complexes that selectively gate traffic between nucleoplasm and cytoplasm. Because transcription happens inside the nucleus and translation happens outside in the cytoplasm, the two processes are uncoupled in space and time. This uncoupling is what makes possible RNA splicing — the removal of introns and joining of exons — an editing step that must be finished, and checked by quality-control machinery, before the mRNA is licensed to leave through a nuclear pore.

2. Cytoplasmic organization: one compartment vs many

A prokaryotic cell has essentially no membrane-bound organelles (though it may have small protein-bound compartments called bacterial microcompartments, e.g. carboxysomes, and elaborate internal membrane folds in some species). Its ribosomes are of the smaller 70S type (30S + 50S subunits), floating free in the cytoplasm or attached to the inner face of the plasma membrane. A eukaryotic cell subdivides its cytoplasm into an entire suite of organelles, each solving a different biochemical problem by isolating incompatible or dangerous reactions:

Eukaryotic ribosomes are the larger 80S type (40S + 60S subunits), found free in cytoplasm or bound to the rough ER. This size difference (70S vs 80S) is not a trivial detail — it is the molecular basis of an entire class of antibiotics (see "Where this matters today").

3. Size, cytoskeleton, and division machinery

Prokaryotic cells are typically 1–5 μm in diameter; eukaryotic cells are typically 10–100 μm — roughly 10 to 1,000 times greater in volume. Prokaryotes divide by binary fission, a comparatively simple process of DNA replication from a single origin followed by septum formation via the FtsZ protein ring (a tubulin homolog). Eukaryotes divide by mitosis, a far more elaborate choreography involving spindle microtubules, centrosomes, and checkpoint-controlled separation of many chromosomes simultaneously — necessary precisely because there are multiple linear chromosomes that must each be correctly partitioned, unlike the single circular chromosome of a bacterium. Eukaryotic cells also possess an extensive, dynamic cytoskeleton (actin filaments, microtubules, intermediate filaments) used for internal transport, shape, and motility; prokaryotes have homologous but structurally simpler cytoskeletal proteins (FtsZ, MreB, crescentin) that support division and shape but do not run the elaborate vesicle-trafficking systems eukaryotes depend on, because prokaryotes largely lack the internal membrane compartments that vesicles would need to shuttle between.

4. Why compartmentalization matters mechanistically

Compartmentalization solves a real biochemical problem: many essential reactions are mutually incompatible if run in the same aqueous space. Lysosomal digestive enzymes function optimally at pH ~4.5 and would degrade cytoplasmic proteins if not sequestered; oxidative phosphorylation requires a sealed membrane across which protons can be pumped to build the electrochemical gradient (chemiosmotic coupling, established by Peter Mitchell) that drives ATP synthase. Peroxisomes generate and immediately neutralize hydrogen peroxide, a reactive molecule that would cause oxidative damage if released into open cytoplasm. By walling these processes into separate organelles, eukaryotic cells can run all of them simultaneously without cross-interference — a scale of biochemical multitasking simply unavailable to a cell with one shared compartment. Compartmentalization also enables sophisticated gene regulation. Because transcription (nucleus) and translation (cytoplasm) are separated by the nuclear envelope, eukaryotic cells gained an additional regulatory layer: nothing can be translated until it has been correctly spliced, capped, polyadenylated, and actively exported through a nuclear pore complex — checkpoints that give eukaryotic gene expression far more control points than prokaryotic gene expression, which is regulated mainly at the level of transcription initiation (e.g., the lac operon).

Resolving the debate: electron microscopy establishes the nucleus/no-nucleus divide

Light microscopy, limited to a resolution of roughly 200 nm by the wavelength of visible light, could show that bacterial cells were small and granular but could not resolve whether they contained internal membranes at all. The definitive answer required transmission electron microscopy (TEM), developed in the 1930s–1950s (Ernst Ruska's electron microscope, 1933; ultrathin sectioning and staining methods refined by Keith Porter, George Palade, and others through the 1940s–50s). TEM achieves resolution below 1 nm because electron wavelengths are thousands of times shorter than visible light. When bacterial cells were thin-sectioned, fixed, and imaged by TEM in the 1950s (foundational work by Chapman and Hillier, and by C.F. Robinow), researchers observed directly that the bacterial genetic material occupied an irregular, unbounded region of lower electron density — the nucleoid — with no surrounding membrane, in stark contrast to the electron-dense, double-membrane-bounded nucleus clearly visible in every eukaryotic cell examined (yeast, protozoa, plant and animal tissue). This was the direct structural proof, not an inference, that prokaryotic cells genuinely lack a nuclear envelope — settling what had been an ambiguous point under light microscopy, where a diffuse nuclear region can be hard to distinguish from a true membrane-bound nucleus. Simultaneously, TEM revealed the internal architecture of eukaryotic cells for the first time: Palade and Porter's work through the 1950s identified and named the endoplasmic reticulum, resolved individual mitochondrial cristae, and visualized the Golgi apparatus's stacked cisternae — organelles that had been suspected from light microscopy (e.g., Camillo Golgi's silver-staining studies from 1898) but never structurally confirmed. This body of work, much of it conducted at the Rockefeller Institute, essentially created modern cell biology as a discipline and earned Palade a share of the 1974 Nobel Prize in Physiology or Medicine.

The endosymbiotic theory: evidence that mitochondria and chloroplasts were once free-living bacteria

A second, related body of evidence addresses why eukaryotic cells have the particular organelles they do — specifically mitochondria and chloroplasts, which are structurally anomalous among organelles because they have two membranes and their own genome. Lynn Margulis revived and rigorously argued (1967, "On the Origin of Mitosomeing Cells," rejected by more than a dozen journals before publication) that mitochondria and chloroplasts originated as free-living bacteria engulfed by an ancestral host cell, which were not digested but retained as permanent endosymbionts. The decisive evidence, accumulated over subsequent decades, includes:

• Mitochondrial and chloroplast DNA is circular, like bacterial chromosomes, not linear like the nuclear chromosomes of their eukaryotic host.
• Mitochondrial and chloroplast ribosomes are the smaller 70S bacterial type, not the 80S cytoplasmic type of the host cell.
• Mitochondrial and chloroplast DNA sequences, when compared phylogenetically, cluster with specific bacterial lineages — mitochondrial genes are most similar to alphaproteobacteria (relatives of Rickettsia); chloroplast genes are most similar to cyanobacteria.
• Both organelles replicate by a fission process resembling bacterial binary fission, independent of the host cell cycle, and are never made de novo — they arise only from pre-existing mitochondria/chloroplasts.
• Both organelles are bounded by a double membrane, consistent with an outer membrane derived from the host's engulfing vesicle and an inner membrane derived from the original bacterial plasma membrane.

This evidence is now overwhelming and constitutes the accepted explanation for the origin of eukaryotic organelles — a striking case where the prokaryote/eukaryote distinction described in this article is not just a static contrast but the record of an ancient evolutionary merger.

Example 1 — Diagnosing cell type from an electron micrograph. A researcher is handed an unlabeled TEM image of an unknown single cell, roughly 3 μm across, with a granular cytoplasm showing no internal membranes, a single irregular electron-lucent region without a bounding membrane, and small ~20 nm particles scattered throughout. What domain of life is this, and what is the evidence? Reasoning: The 3 μm size is consistent with a prokaryote (eukaryotic cells are usually 10–100 μm). The absence of any internal membranes rules out mitochondria, ER, or Golgi. The irregular unbounded electron-lucent region is diagnostic of a nucleoid, not a true nucleus — a genuine nucleus would show a continuous double membrane with visible pores. The ~20 nm particles are consistent with 70S ribosomes (eukaryotic 80S ribosomes are somewhat larger, ~25–30 nm, and the size difference, while subtle by eye, correlates with sedimentation coefficient). Conclusion: this is a prokaryotic cell (Bacterium or Archaeon). To distinguish bacterium from archaeon would require further evidence — such as membrane lipid chemistry (ester- vs ether-linked lipids) or 16S rRNA sequencing — since gross morphology alone cannot separate the two prokaryotic domains.

Example 2 — Quantifying the compartmentalization advantage in ATP yield. Compare aerobic glucose oxidation in a bacterium lacking mitochondria (using its plasma membrane for the electron transport chain) versus a eukaryotic cell using mitochondria, in terms of surface area available for chemiosmotic ATP synthesis. Suppose a bacterial cell is a sphere of radius 1 μm. Its plasma membrane surface area is: A = 4πr² = 4π(1 μm)² ≈ 12.6 μm² This entire surface must serve as both the boundary of the cell and the site of the electron transport chain and ATP synthase. Now suppose a eukaryotic cell of radius 10 μm contains 500 mitochondria, each roughly cylindrical with extensive internal folding (cristae) that amplifies its own inner membrane area roughly fivefold compared to a smooth sphere of the same volume. If each mitochondrion's cristae-folded inner membrane contributes an effective area of ~30 μm², total ETC membrane area available is: 500 × 30 μm² = 15,000 μm² — more than a thousand-fold greater membrane area for oxidative phosphorylation than the entire outer surface of a bacterium of comparable linear scale, packed into a cell whose plasma membrane (4π(10)² ≈ 1,257 μm²) would otherwise be the only option. This quantifies, concretely, why compartmentalizing the electron transport chain into a dedicated, internally folded organelle lets a large eukaryotic cell sustain far higher ATP output than would be possible if it had to rely on its plasma membrane alone — a major reason mitochondria are thought to have been essential to enabling eukaryotic cell size and complexity in the first place.

The modern prokaryote/eukaryote framework, and the endosymbiotic explanation for eukaryotic organelles, owes its establishment substantially to Lynn Margulis, whose insistence on this idea against strong initial resistance is one of the classic stories of a minority hypothesis becoming textbook consensus through accumulating molecular evidence. Margulis was trained in genetics and microbiology and became fascinated with symbiosis as a creative evolutionary force, in contrast to the mid-20th-century emphasis on gradual mutation and selection alone as the drivers of complexity. Working largely at Boston University from the 1970s onward, she synthesized decades of scattered observations — the double membranes of mitochondria and chloroplasts, their bacterial-sized ribosomes, their independent replication — into a single coherent evolutionary narrative: that the eukaryotic cell itself is a chimera, born from an ancient union between a host archaeon-like cell and engulfed bacteria that became permanent, obligate partners rather than prey. Her 1967 paper proposing this in detail was rejected by more than a dozen journals before finally being published, largely because the field at the time favored a view of the nucleus and organelles arising by gradual internal membrane infolding within a single lineage, without any symbiotic merger. It took the arrival of DNA sequencing technology in the following decades — allowing direct comparison of mitochondrial, chloroplast, and bacterial gene sequences — to provide molecular proof that vindicated her hypothesis and converted it from a fringe idea into the accepted account of eukaryotic origins.

The 70S-versus-80S ribosome difference between prokaryotes and eukaryotes is the direct molecular basis of an entire class of clinically vital antibiotics. Drugs such as streptomycin, tetracycline, erythromycin, and chloramphenicol bind selectively to bacterial 70S ribosomal subunits (or their component 30S/50S subunits) and block bacterial protein synthesis while leaving human 80S cytoplasmic ribosomes largely untouched — this selective toxicity is precisely what makes these drugs usable as medicines rather than general poisons. (Some of these drugs do partially affect human mitochondrial ribosomes, which remain bacterial-like 70S ribosomes as a legacy of endosymbiosis — this is the mechanistic explanation for certain antibiotic side effects, such as aminoglycoside-associated ototoxicity.) The absence of a nuclear envelope and membrane-bound organelles in prokaryotes also underlies the design of countless biotechnology platforms: bacteria like E. coli are used as protein-expression factories precisely because their simpler transcription/translation machinery (lacking splicing, and with transcription and translation physically coupled) makes it comparatively straightforward to insert a gene and obtain protein product, though eukaryotic expression systems (yeast, insect, or mammalian cell lines) are required when correct post-translational modification (glycosylation, disulfide bonding in the ER) is essential — for example in manufacturing therapeutic monoclonal antibodies. In agriculture and conservation, understanding chloroplasts as descendants of cyanobacterial endosymbionts informs research into engineering more efficient photosynthesis and into the endosymbiotic relationships (e.g., coral-zooxanthellae symbioses, itself echoing the ancient mitochondrial/chloroplast merger) whose breakdown under climate stress drives coral bleaching. In public health, the prokaryote/eukaryote distinction is the conceptual foundation for distinguishing bacterial infections (treatable with antibiotics targeting prokaryotic-specific machinery) from viral or fungal (eukaryotic) infections requiring entirely different therapeutic strategies, since fungi, being eukaryotes, share far more cellular machinery with human cells and are correspondingly harder to target selectively.

Ask the tutor: How did the very first eukaryotic cell's ancestor manage to engulf a bacterium before it even had the phagocytic machinery that engulfment normally requires?